The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma
The inhibitor of apoptosis protein (IAP) genes are frequently overexpressed in malignancies. Second mitochondria-derived activator of caspase (SMAC) mimetics, which target IAPs, have potential to trigger cancer cell death and sensitize tumor cells to cytotoxic therapy. The aim of this study was to i...
Saved in:
Main Authors: | Zide Chen (Author), Jiehua Chen (Author), Hongyan Liu (Author), Wei Dong (Author), Xuan Huang (Author), Dajun Yang (Author), Jinlin Hou (Author), Xiaoyong Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019) -
The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
by: Huang Q, et al.
Published: (2019) -
Overview of the progress and prospects of SMAC mimetics in cancers: Is it a silver bullet?
by: Almuradova Elvina, et al.
Published: (2022) -
MDM2 inhibitor APG-115 synergizes with ABT-199 to induce cell apoptosis in chronic lymphocytic leukemia
by: Ying Cui, et al.
Published: (2024) -
Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents
by: Nevine M.Y. Elsayed, et al.
Published: (2015)